← Back to Home
❀
Renal Diseases
Disease / Phenomenon
Conditions that impair the kidneys' filtering and balancing roles, affecting waste clearance, fluid regulation, and mineral equilibrium.
Biological Processes of Renal Diseases
Explore the key biological processes that drive renal diseases, from cellular mechanisms through tissue-level responses.
✣
Fibrosis
1 pathway(s)
▸
Fibrosis
1 pathway(s)
▣
TGF-β1 Signaling
Target: TGF-β1
▸
TGF-β1 Signaling
Target: TGF-β1
✣
Inflammation
1 pathway(s)
▸
Inflammation
1 pathway(s)
▣
TLR4/NF-κB Signaling
Target: NF-κB
▸
TLR4/NF-κB Signaling
Target: NF-κB
✣
Mitochondrial Dysfunction
1 pathway(s)
▸
Mitochondrial Dysfunction
1 pathway(s)
▣
ROS Signaling
Target: ROS
▸
ROS Signaling
Target: ROS
✣
Apoptosis
1 pathway(s)
▸
Apoptosis
1 pathway(s)
▣
AKT/mTOR Signaling
Target: GLI-1
▸
AKT/mTOR Signaling
Target: GLI-1
Compounds affecting Renal Diseases
Browse active compounds and their direct impact on renal diseases biological processes, pathways, and biomarkers.
⌬
From Blueberry
▸
From Blueberry
✣
Fibrosis
TGF-β1 Signaling
▸
Fibrosis
TGF-β1 Signaling
✣
Inflammation
TLR4/NF-κB Signaling
▸
Inflammation
TLR4/NF-κB Signaling
⌬
From Milk Thistle
▸
From Milk Thistle
✣
Apoptosis
AKT/mTOR Signaling
▸
Apoptosis
AKT/mTOR Signaling
⌬
From Milk Thistle
▸
From Milk Thistle
✣
Mitochondrial Dysfunction
ROS Signaling
▸
Mitochondrial Dysfunction
ROS Signaling
Ingredients affecting Renal Diseases
Explore therapeutic ingredients and their constituent compounds that modulate renal diseases biology.
♧
1 active compound(s)
▸
1 active compound(s)
⌬
Fibrosis → TGF-β1 Signaling
▸
Fibrosis → TGF-β1 Signaling
♧
2 active compound(s)
▸
2 active compound(s)
⌬
Mitochondrial Dysfunction → ROS Signaling
▸
Mitochondrial Dysfunction → ROS Signaling
⌬
Apoptosis → AKT/mTOR Signaling
▸
Apoptosis → AKT/mTOR Signaling